SCHEMBL23169682

SCHEMBL23169682

c1ccc(-c2cc3ccccc3n2-c2cc(-n3c(-c4ccccc4)cc4ccccc43)cc(-n3c4ccccc4c4ccccc43)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ ATM Q13315 1/20 0.50
▸ HAO1 Q9UJM8 1/20 0.49
▸ APP P05067 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ TSHR P16473 3/20 0.39
▸ IL1R1 P14778 1/20 0.36
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ NTRK1 P04629 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15887972 0.92 KDM4E (0.48) KMT2AL3MBTL1KDM4EATMHAO1
SCHEMBL3862911 0.91 HAO1 (0.49) KMT2AL3MBTL1KDM4EATMHAO1
SCHEMBL1753892 0.91 KMT2A (0.58) KMT2AL3MBTL1KDM4EHAO1APP
SCHEMBL3871381 0.90 HAO1 (0.53) KMT2AL3MBTL1KDM4EATMHAO1
SCHEMBL9886116 0.90 HAO1 (0.53) KMT2AL3MBTL1KDM4EATMHAO1
SCHEMBL15887998 0.89 KDM4E (0.48) KMT2AL3MBTL1KDM4EATMHAO1
SCHEMBL13645511 0.88 HAO1 (0.51) KMT2AL3MBTL1KDM4EATMHAO1
SCHEMBL3861466 0.88 HAO1 (0.51) KMT2AL3MBTL1KDM4EATMHAO1
SCHEMBL17206547 0.86 L3MBTL1 (0.55) KMT2AL3MBTL1KDM4EATMHAO1
SCHEMBL23169738 0.85 KDM4E (0.39) KMT2AL3MBTL1KDM4EATMHAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11665959-B2 Compound, organic electroluminescent device and display equipment WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-30 — — US disclosed
US-11665959-B2 Compound, organic electroluminescent device and display equipment WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-30 — — US disclosed
US-20210098710-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY EQUIPMENT WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11665959-B2 Compound, organic electroluminescent device and display equipment L1CAM, CD99, EPCAM KMT2A 2372/4885L3MBTL1 1420/4885KDM4E 2729/4885
US-20210098710-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY EQUIPMENT L1CAM, CD99, EPCAM KMT2A 2372/4885L3MBTL1 1420/4885KDM4E 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback